Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses

OBJECTIVE: The aim of this study was to identify the risk factors associated with fragility fracture (FF) development in glucocorticoid (GC)-treated patients. METHODS: 127 patients (aged 62±18 years, 63% women) on GC-treatment (mean dose 14.5±14.1 mg/day and duration 47.7±69 months) were included. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Florez, Helena, Hernández-Rodríguez, Jose, Carrasco, Josep Lluis, Prieto-González, Sergio, Muxi, Africa, Filella, Xavier, Ruiz-Gaspà, Silvia, Gómez-Puerta, José A, Cid, Maria, Espinosa, Gerard, Monegal, Ana, Guañabens, Núria, Peris, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Osteoporosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520700/
https://www.ncbi.nlm.nih.gov/pubmed/32917834
http://dx.doi.org/10.1136/rmdopen-2020-001355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520700/
https://www.ncbi.nlm.nih.gov/pubmed/32917834
http://dx.doi.org/10.1136/rmdopen-2020-001355

Ejemplares similares